MGlu 2/3 agonists
US8575214B2 · kind B2 · utility
0Cited by
0References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 29, 2013 |
| Grant date | Nov 5, 2013 |
| Priority date | — |
| Expiry date | Jan 29, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/94
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel mGlu2/3 agonists of the formulawherein R1, R2, and R3 are as defined herein, for use in the treatment of neurological or psychiatric disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.